Adenosine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Adenosine and local guidelines before prescribing.

Antiarrhythmic (purine nucleoside)

Mechanism

Activates A1 receptors, causing transient AV nodal block and interrupting re-entrant tachycardia.

Uses

Regular narrow-complex (AV re-entrant) SVT; diagnostic aid in flutter or broad-complex tachycardia.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
Regular narrow-complex SVT6 mg rapid IV → 12 mg → 18 mgAvoid in irregular wide-complex tachycardia; flush immediately.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

This drug is not covered by a dedicated section of the textbook chapters.

Side effects

Flushing, chest tightness, dyspnoea, transient asystole or bradycardia, sense of doom.

Interactions

Dipyridamole and theophylline interact (potentiate or antagonise); carbamazepine prolongs block.

Contraindications and cautions

Asthma or severe COPD, 2nd/3rd-degree heart block, sick sinus syndrome, long QT

Monitoring

Continuous ECG during use

Pregnancy and breastfeeding

Use where indicated

Renal and hepatic impairment

No adjustment

Overdose and reversal

Effects last seconds; aminophylline reverses

Special advice

Give by rapid bolus with a fast flush, with ECG recording; avoid in asthma, high-grade block and pre-excited AF; warn the patient of brief unpleasant symptoms.